等待开盘 09-01 09:30:00 美东时间
-1.160
-4.02%
Precipio press release (PRPO): Q2 Revenue of $7M (+22.8% Y/Y). Adjusted EBITDA – $0.4M vs. $(0.2)M in Q1-2026. Cash flow - Cash Flow generated from operations was $0.7M in Q2-2026; total increase in c...
08-17 15:40
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.12) per share. This is a 340 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $7.021 million in sales this quarter. This is a 24.18 percent increase over sales of $5.654 million the same per...
08-15 04:39
Precipio, a specialty cancer diagnostics company, reported strong financial results for Q2-2026, with revenue reaching $7.0M, a 22% year-over-year increase. Adjusted EBITDA turned positive at $0.4M, up from -$0.2M in Q1-2026, driven by higher revenues and reduced stock-based compensation. Cash flow improved, ending the quarter with over $3M in cash, up from $1.1M in Q2-2025. CEO Ilan Danieli highlighted the company's operational strength and conf...
08-14 20:00
Precipio ( ($PRPO) ) has issued an announcement. On July 31, 2026, New Haven-ba...
08-01 05:21
Precipio, Inc. will host a Q2-2026 shareholder update call on August 17, 2026, at 5:00 PM ET. The call will cover the company’s current core businesses and include a live Q&A session. CEO Ilan Danieli expressed excitement about Q2 results, highlighting progress in customer acquisition, pipeline expansion, and business growth. Investors can submit questions in advance via email to investors@precipiodx.com or participate during the call by dialing ...
07-31 20:00
Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, is urging shareholders to instruct their brokers to vote their shares by June 14, 2026, at 11:59 p.m. Eastern Time, to ensure a quorum for its Annual Meeting on June 15, 2026. Currently, approximately 42% of shares have been voted, and at least 50% are needed to hold the meeting. If insufficient votes are received, the meeting may need to be adjourned and reconvened, resulting...
06-12 17:00
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) will present at the Planet MicroCap Las Vegas 2026 conference on June 17, 2026, at 9:00 AM local time (12:00 PM EST) at the Bellagio Resort & Hotel. CEO Ilan Danieli and COO Zaki Sabet will host the presentation and answer questions. Precipio aims to expand its shareholder base and raise awareness rather than seek capital. The live presentation and registration details are availab...
06-11 21:00
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $6.711 million in sales this
05-15 05:03
Precipio, Inc. reported first-quarter 2026 revenue of $6.71M, flat from Q4-2025 but up 36% year-over-year. Product revenue declined temporarily due to delayed shipments. Adjusted EBITDA was $(0.16)M, impacted by CMS cuts, product shipment delays, and hiring costs. Cash flow was positive $60K. CEO Ilan Danieli noted underlying growth, particularly in the expanding product pipeline, expecting second-half growth.
05-14 21:00
Precipio, Inc. announced that its 2025 employee stock options granted to management vested due to a 400% increase in its share price from $6.06 to a 10-day VWAP of $30.30. The Company replaced standard time-based vesting with a market-based structure, where options vest upon reaching a specified share price. CEO Ilan Danieli highlighted this as aligning management incentives with shareholders. In 2026, management agreed to a similar structure wit...
05-13 21:00